Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.

about

Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.

Item

http://www.wikidata.org/entity/Q38813392

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Neurotoxicity after high-dose ...... ufficient folinic acid rescue.

@en

type

Item

label

Neurotoxicity after high-dose ...... ufficient folinic acid rescue.

@en

prefLabel

Neurotoxicity after high-dose ...... ufficient folinic acid rescue.

@en

P1476

Neurotoxicity after high-dose ...... sufficient folinic acid rescue

@en

P2093

Ian Joseph Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia

Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.

Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology

Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.

Biochemical and clinical aspects of methotrexate neurotoxicity.

Attentional ability among survivors of leukaemia treated without cranial irradiation.

Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence?

Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system.

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.

Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.

P2888

s00280-017-3304-y

P304

1057-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3304-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ian J Cohen

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085078034

http://www.w3.org/2001/XMLSchema#string

P698

28455583

http://www.w3.org/2001/XMLSchema#string

P921

neurotoxicity

Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.

about

Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921